Preoperative EKG Recommendations for Surgical Clearance

Patient Categories Requiring Preoperative EKG

The American Family Physician recommends preoperative EKG for patients with known cardiovascular disease, those older than 65 years, and patients with cardiovascular risk factors undergoing intermediate or high-risk surgery 1, 2
The American Heart Association, as published in Circulation, indicates that all patients with known cardiovascular disease or dysfunction undergoing cardiac or noncardiac surgery should have a preoperative EKG 3, 4, 5
Patients with known heart disease, peripheral vascular disease, or cerebrovascular disease undergoing intermediate or high-risk surgery should have a preoperative EKG, according to the American Family Physician 1, 2
The American Family Physician also recommends preoperative EKG for patients older than 65 years, regardless of risk factors 2
Patients with one or more clinical risk factors undergoing vascular surgery should have a preoperative EKG, as recommended by the American Family Physician 1, 2

Clinical Value of Preoperative EKG

No cited facts are available for this section

Age Considerations

The American Family Physician recommends preoperative EKG for elderly patients (≥65 years) regardless of other factors 2

Risk-Based Approach

The American College of Cardiology, as summarized by Praxis Medical Insights, suggests that for patients with excellent functional capacity (>10 METs) and no symptoms, surgery can generally proceed despite evidence of previous cardiac issues 6
Poor functional capacity (<4 METs) warrants further cardiac evaluation before surgery, according to Praxis Medical Insights 6
The presence of active cardiac conditions may warrant postponing or canceling elective surgery, as recommended by Praxis Medical Insights 6

Common Pitfalls to Avoid

Ordering "routine" EKGs without clinical indication increases healthcare costs without improving outcomes, according to Praxis Medical Insights 7
Failing to compare with previous EKGs when available may result in misinterpretation of chronic findings as acute, as noted by Praxis Medical Insights 6

Preoperative EKG Timing for Noncardiac Surgery

Risk-Stratified Approach to EKG Timing

The European Society of Cardiology quality indicators specify that intermediate- and high-risk patients should have an ECG "pre-operatively" without mandating a specific timeframe before surgery, and for high-risk patients undergoing non-urgent high-risk surgery, echocardiography should be performed within 3 months preoperatively, suggesting EKG can reasonably be obtained within a similar or shorter timeframe 8
For intermediate- and high-risk patients undergoing noncardiac surgery, obtain a preoperative EKG at the time of preoperative assessment, which can be performed days to weeks before surgery, as long as the patient's clinical status remains stable 8

Clinical Context for Timing

An EKG obtained weeks before surgery remains valid if the patient's clinical status is unchanged 9
Obtain EKG on day of surgery if new cardiac symptoms develop (syncope, new dyspnea, change in angina pattern, palpitations, extreme fatigue) 9

Postoperative EKG Timing

Continue cardiac monitoring for minimum 48-72 hours after uncomplicated cardiac surgery 10, 11
Check troponin and EKG at 24 and 48 hours after surgery in intermediate- and high-risk patients undergoing high-risk noncardiac surgery, and for patients with postoperative myocardial injury, perform cardiac evaluation before hospital discharge 8

Preoperative EKG Guidelines for Patients Undergoing Surgery

Indications for Preoperative EKG

The American College of Cardiology recommends that patients with known cardiovascular disease, significant arrhythmia, peripheral arterial disease, cerebrovascular disease, or structural heart disease undergoing elevated-risk surgery should receive a preoperative resting 12-lead EKG to establish baseline and guide perioperative management 12
Patients with active symptoms of cardiovascular disease undergoing elevated-risk surgery should have preoperative EKG 12
The American College of Cardiology suggests that all patients with at least one clinical risk factor undergoing vascular surgical procedures should have preoperative EKG 13
Even patients with no clinical risk factors undergoing vascular procedures may reasonably receive preoperative EKG 13
For asymptomatic patients without known cardiovascular disease undergoing elevated-risk surgeries, preoperative 12-lead EKG may be considered to establish baseline and guide perioperative management 12
Patients with at least one clinical risk factor undergoing intermediate-risk operative procedures may reasonably receive preoperative EKG 13

Risk Stratification

Routine preoperative resting 12-lead EKG is not recommended for asymptomatic persons undergoing low-risk surgical procedures, as it does not improve outcomes 12
Low-risk surgery does not require EKG for asymptomatic patients 12

Clinical Decision Making

The American College of Cardiology recommends that known cardiovascular disease or active cardiac symptoms should prompt an EKG 12
New abnormalities on preoperative EKG (ST-segment changes, T-wave inversions, LV hypertrophy, pathologic Q-waves, Mobitz type II or higher AV block, bundle branch block, QT prolongation, or atrial fibrillation) should be further evaluated to refine cardiovascular risk assessment 12
A prolonged QT interval on preoperative EKG may inform selection of anesthetics, postoperative antiemetics, or antibiotic therapy 12
Incidental Q-waves or bundle branch block in asymptomatic patients may indicate coronary artery disease but should not automatically lead to coronary revascularization before noncardiac surgery 12

Preoperative Evaluation for Intermediate-Risk Surgery

EKG Recommendations

The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend preoperative 12-lead EKG for patients with known cardiovascular disease, peripheral arterial disease, or cerebrovascular disease undergoing intermediate-risk procedures 14
Hysteroscopy D&C under general anesthesia qualifies as intermediate-risk surgery requiring anesthesia monitoring and potential hemodynamic changes, necessitating an EKG 15
The EKG serves to establish baseline cardiac status and guide perioperative management, particularly important given age-related cardiovascular changes 14

Chest X-Ray Recommendations

The American Society of Anesthesiologists (ASA) states that chest x-ray should NOT be ordered routinely based solely on age 16, 17
Chest x-ray is only indicated when specific clinical indicators are present on history or physical examination, such as active cardiopulmonary symptoms or known cardiopulmonary disease 15, 16
The ASA Task Force explicitly states that preoperative tests should not be ordered routinely but rather on a selective basis for guiding perioperative management 16
Studies demonstrate that routine chest x-rays in asymptomatic elderly patients have low yield for changing management 17
When chest x-rays are obtained without clinical indication, they lead to changes in management in only 0-8.6% of cases 17

Clinical Decision Making

The ACC/AHA guidelines recommend considering the patient's history of heart failure, valvular disease, or arrhythmias when deciding on preoperative testing 18, 19
A focused cardiopulmonary history and examination should be performed to identify patients who may benefit from chest x-ray 15, 16
The decision to order a chest x-ray should be based on the presence of specific clinical indicators, such as dyspnea, orthopnea, or paroxysmal nocturnal dyspnea 15, 16

Preoperative Cardiac Evaluation for Noncardiac Surgery

Introduction to Cardiac Risk Assessment

The American College of Cardiology recommends that the presence of T wave abnormalities suggesting lateral ischemia on a preoperative ECG warrants further cardiac evaluation before proceeding with surgery, particularly if the patient has cardiovascular risk factors or the surgery is intermediate- or high-risk 20, 21

Risk Stratification Based on Surgery Type

For low-risk surgery, routine preoperative ECG is not indicated for asymptomatic patients, and ECG abnormalities alone do not mandate cardiac clearance, according to the American College of Cardiology 20, 21, 22
For intermediate-risk surgery, preoperative ECG is reasonable for patients with at least one clinical risk factor, and abnormal findings warrant further evaluation, as recommended by the American College of Cardiology 20, 21, 22

Significance of T Wave Abnormalities

T wave abnormalities indicating lateral ischemia are clinically significant findings that predict adverse perioperative outcomes, with ST-segment depression and T wave changes on preoperative ECG predicting adverse perioperative cardiac events in patients with established coronary disease 20, 21
Postoperative ECG changes, including T wave abnormalities, confer a 2.2-fold increase in major cardiac complications, from 1.9% to 6.7% 23

Clinical Risk Factors That Mandate Further Evaluation

If the patient has a history of ischemic heart disease, further cardiac evaluation is warranted 23
If the patient has a history of compensated or prior heart failure, further cardiac evaluation is warranted, according to the American Heart Association 21

Active Cardiac Conditions That Require Treatment Before Surgery

Decompensated heart failure requires evaluation and treatment before proceeding with noncardiac surgery, as per the American College of Cardiology guidelines 21
Significant arrhythmias require evaluation and treatment before proceeding with noncardiac surgery 23

Practical Algorithm

The American College of Cardiology recommends determining the surgical risk category, assessing for clinical risk factors, evaluating functional capacity, and pursuing cardiology consultation if necessary 20, 22

Preoperative Cardiac Evaluation for Patients with Cardiovascular Risk Factors

EKG Indication and Guidelines

The American College of Cardiology recommends a preoperative 12-lead EKG for patients with known coronary artery disease undergoing intermediate- or high-risk surgery, as it helps establish baseline cardiac status and guide perioperative management 24, 25, 26
Patients with hypertension are recognized as having a cardiovascular risk factor requiring EKG for intermediate-risk procedures, according to the American Heart Association 24, 25
A smoking history is a specific indication to consider preoperative EKG, as stated by the American Family Physician 24
The combination of multiple cardiovascular risk factors, such as hypertension, coronary artery disease, and smoking, makes EKG reasonable even for intermediate-risk surgery, as recommended by the American College of Cardiology 24, 25, 26

Echocardiography and Functional Capacity Assessment

The American College of Cardiology recommends reserving echocardiography for symptomatic patients with suspected heart failure, suspected severe valvular disease, or poor functional capacity with unclear etiology 26, 27, 28
Assessing functional capacity using metabolic equivalents (METs) is crucial, as patients with poor capacity (<4 METs) may require additional evaluation beyond EKG, according to the American Heart Association 25
Patients with excellent capacity (>10 METs) can generally proceed with surgery and EKG, while those with moderate capacity (4-10 METs) may require EKG and further evaluation, as stated by the American College of Cardiology 25, 26

Risk Stratification and Surgical Risk Category

The American College of Cardiology categorizes surgical risk into high-risk (>5% cardiac risk), intermediate-risk (1-5% cardiac risk), and low-risk (<1% cardiac risk) surgery, and recommends preoperative EKG for intermediate- or high-risk surgery 26
Patients with known coronary artery disease undergoing intermediate- or high-risk surgery absolutely require preoperative EKG, as stated by the American Family Physician 24, 26

Additional Preoperative Considerations

The American College of Cardiology recommends optimizing medical management, including continuing or initiating beta-blockers, starting statins, controlling hypertension, and encouraging smoking cessation, to reduce perioperative cardiac risk 26, 29
Targeting a blood pressure of <130/80 mmHg and controlling stage 3 hypertension (≥180/110 mmHg) before elective surgery is crucial, as stated by the American College of Cardiology 26

Pre-Procedure EKG Guidelines

Indications for Pre-Procedure EKG

The American College of Cardiology and American Heart Association recommend that asymptomatic patients without cardiovascular risk factors should not undergo pre-procedure EKG for low-risk surgery, which is a Class III recommendation (no benefit) for patients undergoing cosmetic procedures, cataract surgery, or minor dermatologic procedures 30
For intermediate-risk surgery, such as intraperitoneal, intrathoracic, orthopedic, or prostate surgery, the American College of Cardiology and American Heart Association recommend ordering an EKG if the patient has at least one cardiovascular risk factor, which is a Class IIa recommendation (reasonable to perform) 30
For high-risk surgery, such as vascular or major emergency procedures, the American College of Cardiology recommends ordering an EKG for all patients with known cardiovascular disease or any clinical risk factor, which is a Class I recommendation (should be performed) 30, 31

ICD-10 Coding Guidelines

The American College of Cardiology recommends using the ICD-10 code Z01.810 for encounter for preprocedural cardiovascular examination when ordering an EKG specifically for pre-surgical clearance in patients without documented cardiovascular disease 31
For patients with documented cardiovascular disease, the American College of Cardiology recommends using the specific diagnosis code instead of the Z-code, such as I10 for essential hypertension, I25.10 for atherosclerotic heart disease, or I50.9 for heart failure 30, 31

Documentation Requirements

The American College of Cardiology recommends documenting the patient's age, cardiovascular risk factors, type and risk category of planned surgery, and functional capacity to ensure proper reimbursement for pre-procedure EKG 30

Preoperative Cardiac Evaluation for Noncardiac Surgery

Introduction to Preoperative Cardiac Workup

The American College of Cardiology recommends a preoperative 12-lead ECG and a risk-stratified approach based on functional capacity and surgery type for patients with known or suspected cardiovascular disease, hypertension, diabetes, or hyperlipidemia undergoing noncardiac surgery 32

Determining Urgency and Surgery Risk Category

The American College of Cardiology suggests proceeding immediately to surgery with perioperative medical management and surveillance for emergency surgery, and deferring comprehensive cardiac evaluation until postoperatively 32
The American College of Cardiology recommends postponing elective surgery and treating active cardiac conditions such as unstable angina, decompensated heart failure, significant arrhythmias, or severe valvular disease before surgery 32

Surgery Risk Stratification

The American College of Cardiology classifies vascular surgery and major emergency procedures as high-risk (>5% cardiac event rate) 33
The American College of Cardiology classifies intraperitoneal, intrathoracic, orthopedic, prostate surgery, and hernia repair as intermediate-risk (1-5% cardiac event rate), although this specific classification is not directly cited, the general risk stratification is 33

Preoperative Evaluation and Testing

The American College of Cardiology recommends obtaining a preoperative 12-lead ECG for patients with known cardiovascular disease, peripheral arterial disease, or cerebrovascular disease undergoing intermediate- or high-risk surgery, as well as for patients with recent chest pain or ischemic equivalent undergoing intermediate- or high-risk surgery 32
The American College of Cardiology suggests that patients with at least one clinical risk factor undergoing intermediate-risk surgery may reasonably obtain an ECG 32
The American Heart Association and the American College of Cardiology suggest that insulin-dependent diabetes mellitus is a clinical risk factor requiring closer perioperative monitoring 34

Functional Capacity and Further Testing

The American College of Cardiology states that functional capacity determines the need for further testing, with patients having excellent capacity (≥10 METs) able to proceed directly to surgery regardless of ECG findings, and those with poor capacity (<4 METs) requiring further risk stratification 32

Clinical Risk Stratification

The American College of Cardiology recommends counting the number of clinical risk factors, including high-risk surgery, ischemic heart disease, congestive heart failure, cerebrovascular disease, insulin-dependent diabetes mellitus, and renal insufficiency, to guide risk-based management 32
The American College of Cardiology suggests that patients with 0 risk factors can proceed to surgery without further testing, while those with 1-2 risk factors and poor functional capacity may require noninvasive testing if results would change management 32

Selective Use of Noninvasive Stress Testing

The American College of Cardiology recommends noninvasive stress testing for patients with poor functional capacity (<4 METs) and ≥3 clinical risk factors undergoing vascular surgery, only if results would change management 32
The American College of Cardiology suggests that exercise ECG is the first choice for ambulatory patients with normal baseline ECG, while pharmacological stress imaging is suitable for patients with abnormal baseline ECG or unable to exercise 35

Echocardiography Indications

The American College of Cardiology recommends echocardiography for patients with current or poorly controlled heart failure, and for symptomatic patients with suspected severe valvular disease 35
The American College of Cardiology suggests that echocardiography is reasonable for patients with prior heart failure and no recent evaluation, and for patients with dyspnea of unknown origin 35

Perioperative Medical Optimization

The American College of Cardiology recommends optimizing hypertension management, with stage 3 hypertension requiring control before elective surgery, and continuing all preoperative antihypertensive medications through the perioperative period 33
The American College of Cardiology suggests starting beta-blockers in patients with ≥1 clinical risk factor, and continuing beta-blockers in patients already taking them, but advises against starting high-dose beta-blockers immediately preoperatively 32
The American College of Cardiology recommends starting statins ideally 30 days before surgery in all patients with atherosclerotic cardiovascular disease, especially those undergoing vascular surgery, and using long-acting formulations 32
The European Heart Journal suggests optimizing glycemic control while avoiding hypoglycemia in patients with diabetes, and the American College of Cardiology recommends closer perioperative monitoring for patients with insulin-dependent diabetes mellitus [36] [32]

Cardiac Clearance for Intermediate‑Risk Surgery (ACC/AHA Guideline‑Based Recommendations)

ECG Indications and Interpretation

The ACC/AHA guidelines recommend obtaining a pre‑operative 12‑lead ECG for patients with known cardiovascular disease (e.g., peripheral arterial disease, prior retinal artery occlusion) who are scheduled for intermediate‑risk procedures. [37][38]
Absence of acute ST‑segment elevation or depression on the ECG indicates no active myocardial ischemia and does not require postponement of surgery. 37

Functional Capacity Assessment

Ambulation with a walker without dyspnea, chest pain, dizziness, or exercise intolerance demonstrates functional capacity likely ≥ 4 METs, the threshold above which further stress testing is generally unnecessary. [39][37]38

Clinical Risk‑Factor Evaluation (Revised Cardiac Risk Index)

The patient has the following clinical risk factors: peripheral arterial disease, prior myocardial infarction (Q‑wave changes), stage 3a chronic kidney disease, and an intermediate‑risk operation (rectal prolapse repair). Each of these factors is recognized by the ACC/AHA guidelines as contributing to peri‑operative cardiac risk. 37
When multiple risk factors are present but functional capacity is adequate (≥ 4 METs), non‑invasive stress testing should be considered only if the results would alter management. [37][38]

Assessment of Active Cardiac Conditions

No evidence of unstable angina or recent myocardial infarction (patient asymptomatic and ECG without acute changes). 37
No signs of decompensated heart failure (clear lungs, no volume overload, stable vitals). [37][38]
No significant arrhythmias (normal sinus rhythm). 37
No severe valvular disease (no murmurs on examination). 37
Because no active cardiac conditions are present, the guidelines advise that surgery should not be postponed. [37][38]

Peri‑operative Medical Optimization

Initiation of a β‑blocker may be reasonable in patients with multiple risk factors, but high‑dose titration should not be started immediately before surgery. 40
Aspirin should be held according to the surgical team’s instructions for colonoscopy with potential polypectomy. 41

Documentation Recommendations

Record acknowledgment of prior anteroseptal myocardial infarction (ECG Q‑waves) without acute ischemia.
Document adequate functional capacity for intermediate‑risk surgery. 39
Note stable clinical status with no active cardiac conditions. [37][38]
Confirm continuation of statin therapy (e.g., atorvastatin) peri‑operatively.
Recommend enhanced peri‑operative cardiac monitoring and postoperative troponin surveillance.

Avoiding Unnecessary Testing and Miscommunication

Non‑invasive stress testing for patients with 1–2 clinical risk factors and adequate functional capacity undergoing intermediate‑risk surgery is justified only if the outcome would change management. [37][38]
The phrase “cleared for surgery” should be avoided; instead, state that “the patient may proceed with the planned intermediate‑risk surgery with guideline‑directed medical therapy and enhanced peri‑operative cardiac surveillance.” 39

Uncommon ECG Abnormalities Requiring Preoperative Evaluation

ECG Findings That Prompt Immediate Concern

The 2024 ACC/AHA guidelines list the following uncommon ECG abnormalities as requiring further cardiovascular evaluation before non‑cardiac surgery because they may indicate active ischemia, significant conduction disease, or structural heart disease:

Recommendations for Obtaining a Pre‑operative ECG

Class IIa – A 12‑lead ECG is reasonable for patients with known cardiovascular disease (e.g., coronary artery disease, prior arrhythmia, peripheral arterial disease, cerebrovascular disease, structural heart disease) or active cardiovascular symptoms (e.g., chest pain, dyspnea, palpitations, syncope) who are scheduled for elevated‑risk surgery 42.
Class IIb – For asymptomatic patients without known cardiovascular disease undergoing elevated‑risk surgery, a pre‑operative ECG may be considered to establish a baseline 42.
Class III – Routine pre‑operative ECG is not recommended for asymptomatic patients undergoing low‑risk procedures, as it does not improve outcomes and adds unnecessary cost 42.

Management of Specific Abnormal ECG Findings

Significant QT prolongation – Document the corrected QT interval, review all medications for QT‑prolonging potential, and coordinate with the anesthesia team to avoid agents such as sevoflurane, droperidol, ondansetron, fluoroquinolones, and macrolides 42.
Pathologic Q‑waves or new bundle‑branch block in asymptomatic patients – Recognize these may signal underlying coronary artery disease, but do not proceed directly to coronary revascularization; instead, establish a baseline ECG, implement enhanced peri‑operative cardiac monitoring, and consider further cardiac testing only if clinical context warrants 42.
New atrial fibrillation – Perform rate‑control assessment, calculate CHA₂DS₂‑VASc score, and consider anticoagulation when appropriate; optimize rhythm or rate control before surgery 42.
High‑degree AV block (Mobitz II or complete block) – Obtain cardiology consultation promptly; evaluate need for temporary or permanent pacemaker placement prior to the operative procedure 42.
Active cardiac conditions (e.g., symptomatic ventricular arrhythmias, uncontrolled supraventricular arrhythmias, new high‑grade AV block) – Postpone elective surgery and treat the cardiac condition first 42.

Beta‑blocker therapy – Continue beta‑blockers in patients already receiving them; consider initiating beta‑blockade in patients with at least one clinical risk factor, but avoid high‑dose initiation immediately before surgery 42.
Hypertension control – For patients with stage 3 hypertension (≥180/110 mmHg), achieve blood‑pressure control before elective surgery and continue all antihypertensive agents peri‑operatively 42.

Common Pitfalls to Avoid

Do not order routine ECGs for asymptomatic patients undergoing low‑risk surgery; this practice raises costs without improving clinical outcomes 42.
Do not automatically cancel surgery for incidental ECG findings such as old Q‑waves or bundle‑branch block in asymptomatic patients with good functional capacity; document the findings and proceed with enhanced monitoring 42.
Do not pursue coronary revascularization solely to “clear” a patient for non‑cardiac surgery, as this strategy does not improve peri‑operative outcomes unless revascularization is independently indicated 42.
Do not overlook significant QT prolongation; failure to recognize and communicate this risk can precipitate peri‑operative torsades de pointes when QT‑prolonging drugs are administered 42.

Preoperative Cardiac Evaluation for Vascular Surgery

1. Evidence Against Routine Pre‑operative Cardiac Testing

Routine coronary revascularization does not improve peri‑operative outcomes in stable patients undergoing vascular surgery. The CARP randomized trial (high‑quality RCT) showed no mortality or myocardial‑infarction benefit, supporting a Class III (no benefit) recommendation. 43
In 510 patients with significant coronary stenosis, pre‑operative revascularization yielded mortality of 22 % versus 23 % with optimal medical therapy, and peri‑operative MI rates of 12 % vs 14 %. These identical outcomes reinforce that routine revascularization is unnecessary. 44
The DECREASE‑V pilot study found that prophylactic coronary revascularization in patients with extensive ischemia on stress imaging did not improve immediate postoperative outcomes nor 2.8‑year survival. (Class III) 44
Resting left‑ventricular systolic function alone is not a reliable predictor of peri‑operative ischemic events. Hence routine echocardiography in stable patients adds little value. 43

2. When Pre‑operative Echocardiography Is Indicated

Current or worsening heart‑failure symptoms (e.g., dyspnea, orthopnea, peripheral edema). Class I recommendation. 45
History of heart failure without an echocardiographic assessment in the past 12 months. Class I. 45
Unexplained dyspnea requiring evaluation of left‑ventricular function. Class I. 45
Suspected severe valvular disease based on physical examination (significant murmur). Class I. 45

3. When Non‑invasive Stress Testing Is Indicated

All three criteria must be met:
These conditions constitute a Class IIa recommendation for selective stress testing. [43][46][47][48]49
Diagnostic performance: Dobutamine stress echocardiography has a sensitivity of ~85 % and specificity of ~70 % for predicting peri‑operative cardiac death or myocardial infarction; all patients who suffered cardiac complications in the cited study had positive tests. (Evidence level B) 47
Extent of reversible ischemia correlates with risk: Presence of > 3 reversible perfusion defects is associated with significantly higher peri‑operative event rates. (Evidence level B) 47

4. Baseline Electrocardiogram

All patients with cardiovascular risk undergoing vascular surgery should obtain a pre‑operative 12‑lead ECG to identify high‑risk findings (ST‑segment changes, pathologic Q‑waves, new bundle‑branch block, significant arrhythmias). This is a Class IIa recommendation. [43][45]49

5. Optimized Medical Therapy Over Routine Testing

Beta‑blockers: Continue or initiate peri‑operatively, but avoid high‑dose initiation immediately before surgery because it increases stroke and mortality risk. (Evidence level B)
Statins: Start or continue at least 30 days before vascular surgery; associated with a modest mortality reduction (≈ 1.8 % vs 2.3 %). (Evidence level B) 44
Blood‑pressure control: Target < 130/80 mm Hg; defer elective surgery if BP ≥ 180/110 mm Hg. (Evidence level C)
Aspirin: Continue only if already prescribed for secondary prevention; routine initiation does not lower peri‑operative events and raises bleeding risk. (Evidence level B)
Diabetes management: Optimize glycemic control while avoiding hypoglycemia. (Evidence level C)
Collectively, these measures are supported by high‑quality trial data and are preferred to routine cardiac imaging or revascularization.* [43][48]44

6. Common Pitfalls to Avoid

Do not order stress testing “just to be thorough” in stable patients with reasonable functional capacity; it leads to false‑positive results and unnecessary downstream interventions without outcome benefit. (Class III) [43][48]
Do not pursue coronary revascularization solely to “clear” a patient for surgery. Indications for revascularization should be identical to those in the non‑peri‑operative setting (e.g., left‑main disease, symptomatic multivessel disease despite optimal medical therapy). (Class III) [43][46]48
Do not assume that detection of ischemia mandates intervention. The DECREASE‑II trial showed extensive ischemia is a risk marker but did not demonstrate benefit from revascularization. (Class III) [43][48]
Do not omit the baseline ECG even when echo and stress testing are deemed unnecessary; it remains a reasonable, low‑cost screening tool. (Class IIa) [43][49]

7. Bottom‑Line Recommendation

For most stable patients with hypertension, diabetes, and prior myocardial infarction scheduled for major vascular surgery, proceed directly to surgery with a baseline ECG and optimized medical therapy (beta‑blockers, statins, blood‑pressure and diabetes control). Reserve echocardiography for symptomatic heart failure or suspected severe valvular disease, and reserve stress testing for the rare patient who has poor functional capacity, multiple risk factors, and where the result would genuinely alter surgical or anesthetic planning. (Class I) [43][48][45][47]

ECG Indications and Risks in Adult Patients

Pre‑operative Electrocardiogram Use

For patients older than 40 years undergoing any surgical procedure, a pre‑operative ECG is recommended to assess baseline cardiac status. Class IIa recommendation. 50
In intermediate‑ or high‑risk surgeries, an ECG is considered reasonable for patients with known cardiovascular disease or at least one clinical risk factor (e.g., hypertension, diabetes, smoking). Class IIb recommendation. 50

Screening Electrocardiogram in Asymptomatic Adults

A baseline ECG may be obtained in asymptomatic adults older than 40 years as a general screening measure to establish cardiac status, not to evaluate non‑cardiac symptoms. Class IIa recommendation. 50
Women aged 50 years or older who present with typical or atypical chest pain should receive a screening ECG. Class IIa recommendation. 51
Women with diabetes mellitus or multiple metabolic‑syndrome risk factors who also have cardiac symptoms should undergo a screening ECG. Class IIa recommendation. 51

Electrocardiogram for Evaluation of Cardiac Symptoms

An ECG is indicated when a patient exhibits symptoms suggestive of cardiovascular disease, such as syncope, chest pain, dyspnea, palpitations, or unexplained extreme fatigue. Class I recommendation. 52

Harms and Cost of Unnecessary Routine ECGs

Ordering routine ECGs in patients without cardiac symptoms or risk factors increases health‑care costs without demonstrable improvement in clinical outcomes. Class III (harmful). 53
Unnecessary ECGs generate false‑positive findings that lead to downstream testing, patient anxiety, and potential overtreatment. Class III (harmful). 53

Preoperative Stress Echocardiography in Patients ≥ 60 Years: Evidence‑Based Recommendations

1. General Indications & Contra‑Indications

Age ≥ 60 years alone is not an indication for pre‑operative stress echocardiography; routine testing in this age group is a Class III (no benefit) recommendation (ACC/AHA 2024) 54.
Adequate functional capacity (≥ 4 METs) eliminates the need for stress testing regardless of age or other risk factors (Class III) 54.
Patients with zero clinical risk factors or with adequate functional capacity should proceed directly to surgery without stress testing (Class III) 55.

2. Criteria Required for Consideration of Stress Echocardiography

Criterion	Definition (Evidence)	Strength / Class
Poor functional capacity	< 4 METs, inability to climb two flights of stairs, inability to walk four blocks without dyspnea/chest pain/fatigue, or DASI score ≤ 34	Class IIb (intermediate‑risk) / Class IIa (vascular) [56]
Multiple clinical risk factors (≥ 3)	Prior ischemic heart disease and/or prior heart failure (each counts as a risk factor)	Class IIb / IIa [55]
Test result would alter management	Findings that would lead to intensified medical therapy, modification of the anesthetic plan, or postponement of surgery	Class IIb / IIa [55]

The presence of a positive stress test does not mandate coronary revascularization; the CARP trial showed no mortality or myocardial‑infarction benefit from prophylactic revascularization before vascular surgery (Class III) 54.

3. Pre‑operative Cardiac Assessment (All Patients ≥ 65 Years with CV Risk)

Baseline 12‑lead ECG is recommended for all patients ≥ 65 years with cardiovascular risk factors undergoing intermediate‑ or high‑risk surgery (Class I) (ACC/AHA 2024) 57.
Medical optimization is preferred over routine imaging (ACC/AHA 2024) 54. Specific measures:
- Continue beta‑blockers in patients already on them (Class I) 54.
- Initiate or continue statins at least 30 days before surgery (Class I) 54.
- Achieve blood‑pressure control < 130/80 mmHg; defer elective surgery if BP ≥ 180/110 mmHg (Class I) 54.
- Optimize diabetes control while avoiding hypoglycemia (Class I) 54.

4. Performance Characteristics of Dobutamine Stress Echocardiography

Negative predictive value (NPV) of 93–100 % for identifying low‑risk patients (Class IIb) 58.
A positive test does not require coronary revascularization; contemporary randomized trials demonstrate no peri‑operative benefit from prophylactic intervention (Class III) 54.

5. Situations Where Stress Testing Is Explicitly Not Recommended (Class III)

Adequate functional capacity (≥ 4 METs) irrespective of age.
Low‑risk patients (Revised Cardiac Risk Index = 0) (ACC/AHA 2024) 58.
Asymptomatic patients with good exercise tolerance (ACC/AHA 2007) 55.
Routine testing solely to “be thorough” (leads to false‑positives and unnecessary downstream procedures) (ACC/AHA 2024) 54.

6. Common Pitfalls to Avoid

Do not order stress testing based only on age; functional capacity and clinical risk factors drive decision‑making (ACC/AHA 2007 & 2024) [57][54].
Do not pursue coronary revascularization solely to “clear” a patient for surgery; the CARP trial showed identical mortality (22 % vs 23 %) and MI rates (12 % vs 14 %) with or without prophylactic revascularization (Class III) 54.
Do not assume that detection of reversible ischemia mandates intervention; reversible defects are prognostic markers but revascularization has not demonstrated peri‑operative outcome benefit (ACC/AHA 2007 & 2024) [55][56]54.

7. Evidence Quality

The 2024 ACC/AHA guideline represents the highest‑quality evidence (Class I‑III recommendations based on high‑quality RCTs, including the CARP trial) and supersedes prior 2014 and 2007 guidelines (ACC/AHA) [54][59].
Recommendations against routine pre‑operative stress testing are grounded in high‑quality randomized controlled trials showing no mortality or myocardial‑infarction benefit from routine coronary revascularization in the peri‑operative setting (Class III) [54][59].